跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACARIZAX (American house dust mite extract and European house dust mite extract) SUBLINGUAL TABLET - TGA Drug Approval Details
Approvals
/
TGA
/
ACARIZAX (American house dust mite extract and European house dust mite extract) SUBLINGUAL TABLET
Approved
STANDARD
ACARIZAX (American house dust mite extract and European house dust mite extract) SUBLINGUAL TABLET
Seqirus Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e7dfbf0098c19a28
Company
Seqirus Pty Ltd
Type
Standard
Approval Details
Approval Id
e7dfbf0098c19a28
Product Name
ACARIZAX (American house dust mite extract and European house dust mite extract) SUBLINGUAL TABLET
Artg Id
250392
Artg Name
ACARIZAX Standardised allergen extract from American house dust mite extract & European house dust mite extract 12 SQ-HDM sublingual tablet
Sponsor
Seqirus Pty Ltd
Company Detail Path
/organization/seqirus-pty-ltd
Artg Date
2016-08-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/92097cb91465a7ec0dd3e0f741def454.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/81a9b9c93a9112ad41a26d4dfc202aae.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e7dfbf0098c19a28
Type
Standard
Back to TGA Approvals